Method and apparatus for determining an analyte concentration in a sample having interferents

• US 8,620,397 B2
• Filed: 10/05/2009
• Issued: 12/31/2013
• Est. Priority Date: 10/21/2004
• Status: Expired due to Fees

• Current Assignee: OptiScan Biomedical Corporation
• Original Assignee: OptiScan Biomedical Corporation
• Inventors: Sterling, Bernhard B., Hall, W. Dale, Witte, Kenneth G., Wechsler, Mark, Zheng, Peng, Keenan, Richard
• Primary Examiner(s): WINAKUR, ERIC FRANK
• Application Number:
  US12/573,821
• Publication Number:
  US 20100221762A1
• Time in Patent Office: 1,548 Days
• Field of Search: 600/309, 600/310, 600/322, 422/68.1, 422/82.05, 422/82.06
• US Class Current: 600/322
• CPC Class Codes: A61B 2560/0223 of calibration, e.g. protocols for calibrating sensors
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/14535 for measuring haematocrit
• CPC Class Codes: A61B 5/14546 for measuring analytes not otherwise provided for, e.g. ions, cytochromes
• CPC Class Codes: A61B 5/1459 invasive, e.g. introduced into the body by a catheter A61B5/1464 takes precedence
• CPC Class Codes: A61B 5/1495 Calibrating or testing of in-vivo probes
• CPC Class Codes: A61M 2230/20 Blood composition characteristics
• CPC Class Codes: A61M 5/14212 Pumping with an aspiration and an expulsion action
• CPC Class Codes: G01N 21/274 Calibration, base line adjustment, drift correction
• CPC Class Codes: G01N 21/35 using infrared light G01N21/39 takes precedence
• CPC Class Codes: G01N 2201/1215 for interfering gases
• CPC Class Codes: G01N 2201/127 Calibration; base line adjustment; drift compensation
• CPC Class Codes: G01N 35/00693 Calibration
• CPC Class Codes: G01N 35/00712 Automatic status testing, e.g. at start-up or periodic

Abstract

A method and apparatus are described that permit an analyte concentration to be estimated from a measurement in the presence of compounds that interfere with the measurement. The method reduces the error in the analyte concentration in the presence of interferents. The method includes the use of a set of measurements obtained for a large population having a range of known analyte and interfering compound concentrations. From a sample measurement, which may or may not be one of the population, likely present interferents are identified, and a calibration vector is calculated.

Claims

1. A method for estimating the concentration of an analyte in a fluid sample, the method comprising:

drawing a fluid sample into an automated monitoring system connected to a patient;

using the system to separate a first interferent from the fluid sample, the remainder comprising a fluid analysis sample;

performing a measurement of the fluid analysis sample;

identifying, based on the measurement of the fluid analysis sample, a second interferent to the estimation of the analyte, the second interferent located in the fluid analysis sample;

calculating a calibration constant which reduces error attributable to the second interferent, the calibration constant based at least partly on the measurement of the fluid analysis sample identifying the second interferent;

applying the calibration constant to the measurement; and

estimating, based on the calibrated measurement, the analyte concentration in the fluid analysis sample.

2. The method of claim 1, wherein the calculating a calibration constant is done without information on the concentration in the analysis sample of the second interferent.

3. The method of claim 1, wherein the fluid sample is a sample from a person, wherein the identifying includes comparing the measurement with population measurements modified to include concentrations of the second interferent, and where the population does not necessarily include the person.

4. The method of claim 1, where the fluid sample includes at least one component of blood, and the analyte is glucose.

5. The method of claim 1, where the fluid sample comprises blood, the first interferent comprises red blood cells, and the separating comprises filtering or centrifuging the sample.

6. The method of claim 1, where the fluid sample comprises at least one component of blood, and the first interferent comprises an exogenous interferent.

7. The method of claim 1, where the measurement is a spectrum.

8. The method of claim 7, wherein the calibration constant is a vector that is not required to be perpendicular to a spectrum of the second interferent.

9. The method of claim 1, where the calculating minimizes errors in the calibration constant due to the presence of the second interferent in the analysis sample.

10. A system for estimating the concentration of an analyte in a sample, the system comprising:

a fluid network configured to connect to a patient and draw fluid samples therefrom;

a separating apparatus configured to receive the fluid sample and separate a first interferent from the sample, the remainder comprising an analysis sample;

an apparatus configured to perform a measurement of the analysis sample;

an identifying apparatus configured to identify, based on the measurement of the analysis sample, a second interferent to the estimation of the analyte in the sample, the second interferent located in the analysis sample;

a calibration processor configured to calculate a calibration constant which reduces error attributable to the second interferent, the calibration constant based at least partly on the measurement of the fluid analysis sample identifying the second interferent;

the calibration processor further configured to apply the calibration constant to the measurement; and

an estimating apparatus configured to estimate, based on the calibrated measurement, the analyte concentration in the sample.

11. The system of claim 10, wherein the separating apparatuses comprises a filter or a centrifuge.

12. The system of claim 10, wherein the first interferent comprises an endogenous interferent and the second interferent comprises an exogenous interferent.

13. The system of claim 10, wherein the sample comprises blood, the first interferent comprises blood cells, and the second interferent comprises a chemical species.

14. The system of claim 10, wherein the apparatus configured to perform a measurement comprises a spectroscope.

15. The system of claim 14, wherein the calibration processor is configured to calculate the calibration constant such that the calibration constant is a vector that is not required to be perpendicular to a spectrum of the second interferent.

16. An analyte detection system comprising:

a fluid network configured to be connected to a patient and receive periodic sample withdrawals therefrom;

a separator for separating a first interferent from a sample to provide an analysis sample;

a sensor configured to provide information relating to a measurement of an analyte in the analysis sample;

a processor; and

a computer storage medium having stored program instructions executable by the processor such that the system is configured to;

identify, based on the measurement of the analysis sample after the first interferent has been separated, a second interferent to the estimation of the analyte in the sample;

calculate, based on the identified second interferent, a calibration which reduces error attributable to the second interferent, the calibration comprising determining a calibration constant;

apply the calibration to the measurement; and

estimate, based on the calibrated measurement, the analyte concentration in the sample.

17. The analyte detection system of claim 16, wherein the separator comprises a filter or a centrifuge.

18. The analyte detection system of claim 16, wherein the sensor comprises a spectroscope.

19. The analyte detection system of claim 16, wherein the sample comprises blood, the first interferent comprises red blood cells, and the second interferent comprises at least one of an endogenous interferent or an exogenous interferent.

20. The analyte detection system of claim 16, wherein the system is configured to calculate the calibration without information on the concentration in the analysis sample of the second interferent.

21. A method for determining a concentration of an analyte in a portion of a fluid sample from a patient, the method comprising:

providing a fluid handling system in fluid communication with a fluid source in a patient, the fluid handling system configured to draw a plurality of fluid samples while in continuous fluid communication with the fluid source in the patient, said plurality of fluid samples comprising at least a first fluid sample and a second fluid sample, the second fluid sample drawn after the first fluid sample;

drawing, via the fluid handling system, the first fluid sample from the patient, the first fluid sample comprising blood or a component of blood;

transporting, via the fluid handling system, a portion of the first fluid sample to an analysis system;

removing a first interference from the first fluid sample;

identifying based on a measurement of the first fluid sample, a second interference to a determination of a concentration of an analyte in the first fluid sample, the second interference located in the first fluid sample;

correcting for the second interference by using the measurement of the first fluid sample to calculate a calibration constant;

applying the calibration constant to the measurement;

wherein the fluid handling system is configured to remain in fluid communication with the fluid source in the patient during said drawing, said transporting, and said correcting, and

wherein said correcting occurs before drawing the second fluid sample from the fluid source in the patient.

22. The method of claim 21, wherein said first interference comprises blood cells, and said removing comprises centrifuging or filtering the portion of the first fluid sample.

23. The method of claim 21, wherein said analysis system comprises a spectroscope, and said second interference comprises a substance having spectroscopic features that overlap spectroscopic features of the analyte.

24. The method of claim 23, wherein the first fluid sample comprises blood, and the portion of the first fluid sample comprises plasma.

25. The method of claim 23, wherein the analyte comprises at least one of glucose, blood urea nitrogen, or lactate.

26. The method of claim 23, wherein the interference comprises at least one of sodium bicarbonate and urea.

27. The method of claim 21, further comprising:

drawing, via the fluid handling system, the second fluid sample from the patient, the second fluid sample comprising blood or a component of blood;

transporting, via the fluid handling system, a portion of the second fluid sample to the analysis system; and

correcting for an interference to a determination of a concentration of said analyte in the portion of the second fluid sample,

wherein the fluid handling system is configured to remain in fluid communication with the fluid source in the patient during said drawing, said transporting, and said correcting of the second fluid sample.